Stock Pulse
3M (MMM) reported strong Q4 2024 earnings, exceeding revenue expectations and increasing its dividend [7], [9]. The company is focusing on operational improvements, including supply chain efficiency and innovation, while addressing legacy legal issues like PFAS and earplug lawsuits [6], [7]. 3M spun off its healthcare division, Solventum (SOLV), which has ambitious growth targets [8]. Despite these positive developments, 3M faces challenges including declining organic revenue, falling EPS, and high debt levels [1], [5]. External factors like market volatility and potential tariffs also contribute to uncertainty [2]. The upcoming Q1 2025 earnings call on April 22nd will be a key opportunity for the company to address investor concerns and outline its future strategy [3].